1. Gorden GEL. The market status of non-patent drugs in China [in Chinese]. 2010 China Pharmaceutical Industry Report. Beijing: Beijing Science Press; 2010. p. 104–129.
2. Chinese State Development and Reform Commission. A notice of adjusting the drug pricing list [in Chinese]. Document no. 429. Beijing: State Development and Reform Commission; 2010.
3. Chinese Ministry of Health, State Council Office for Correcting Illegitimate Practice, National Development and Reform Commission, Ministry of Supervision, Ministry of Finance, State Administration for Industry and Commerce, State Food and Drug Administration. The normalization of drug bulk procurement in medical institutions [in Chinese]. Document no. 64. Beijing: Chinese State Council Office; 2010. Available at: www.nhfpc.gov.cn . Accessed 15 July 2010.
4. Chaudhury RR. Implementation of a programme of rational use of drugs in Delhi State. In: International experience in rational use of drugs. vol 2. Bangkok: The College of Public Health, Chulalongkorn University and UNESCO; 1994. p. 108–123.
5. Chinese Pharmaceutical Association, Research Center for Medicinal Policy pharmaceutical information brief. 2013. Available at: www.phirda.com . Accessed 13 Dec 2013.